Phreesia, Inc. (NYSE:PHR) SVP Sells $106,761.27 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 4,499 shares of the firm’s stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.73, for a total transaction of $106,761.27. Following the completion of the transaction, the senior vice president now directly owns 217,239 shares of the company’s stock, valued at $5,155,081.47. This represents a 2.03 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

David Linetsky also recently made the following trade(s):

• On Tuesday, April 8th, David Linetsky sold 3,944 shares of Phreesia stock. The shares were sold at an average price of $23.85, for a total value of $94,064.40.
• On Tuesday, March 18th, David Linetsky sold 39 shares of Phreesia stock. The shares were sold at an average price of $26.95, for a total value of $1,051.05.
• On Thursday, February 13th, David Linetsky sold 11,616 shares of Phreesia stock. The stock was sold at an average price of $29.70, for a total value of $344,995.20.
• On Friday, February 7th, David Linetsky sold 300 shares of Phreesia stock. The shares were sold at an average price of $29.52, for a total value of $8,856.00.
• On Wednesday, February 5th, David Linetsky sold 720 shares of Phreesia stock. The stock was sold at an average price of $29.50, for a total transaction of $21,240.00.
• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The stock was sold at an average price of $29.68, for a total transaction of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $321,103.80.

Phreesia Trading Up 0.1 %

Shares of NYSE:PHR opened at $23.92 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The stock’s 50-day moving average is $26.07 and its 200-day moving average is $24.31. The company has a market cap of $1.41 billion, a P/E ratio of -16.27 and a beta of 0.82. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. Deerfield Management Company L.P. Series C lifted its holdings in shares of Phreesia by 133.6% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock worth $31,999,000 after buying an additional 727,384 shares during the last quarter. Greenhouse Funds LLLP increased its position in Phreesia by 27.9% during the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after acquiring an additional 626,579 shares during the period. Park West Asset Management LLC acquired a new position in Phreesia during the 4th quarter valued at $10,657,000. Millennium Management LLC boosted its holdings in Phreesia by 83.2% in the 4th quarter. Millennium Management LLC now owns 653,634 shares of the company’s stock valued at $16,445,000 after purchasing an additional 296,863 shares during the period. Finally, ExodusPoint Capital Management LP grew its position in Phreesia by 448.6% in the 4th quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company’s stock worth $4,402,000 after purchasing an additional 143,077 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on PHR shares. Citigroup boosted their target price on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Canaccord Genuity Group lifted their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. DA Davidson dropped their price target on shares of Phreesia from $36.00 to $34.00 and set a “buy” rating on the stock in a research note on Monday, April 14th. Finally, Piper Sandler restated an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia has a consensus rating of “Buy” and a consensus target price of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.